Global Postmenopausal Vaginal Atrophy Drugs Market Insights, Forecast to 2025

Global Postmenopausal Vaginal Atrophy Drugs Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Postmenopausal Vaginal Atrophy Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size Growth Rate by Product
1.4.2 Premarin
1.4.3 Vagifem
1.4.4 Estrace
1.4.5 Estring
1.4.6 Femring
1.5 Market by End User
1.5.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size Growth Rate by End User
1.5.2 Vaginal Gels
1.5.3 Creams
1.5.4 Tablets
1.5.5 Rings
1.5.6 Patches
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Postmenopausal Vaginal Atrophy Drugs Market Size
2.1.1 Global Postmenopausal Vaginal Atrophy Drugs Revenue 2014-2025
2.1.2 Global Postmenopausal Vaginal Atrophy Drugs Sales 2014-2025
2.2 Postmenopausal Vaginal Atrophy Drugs Growth Rate by Regions
2.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales by Regions
2.2.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Postmenopausal Vaginal Atrophy Drugs Sales by Manufacturers
3.1.1 Postmenopausal Vaginal Atrophy Drugs Sales by Manufacturers
3.1.2 Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Manufacturers
3.1.3 Global Postmenopausal Vaginal Atrophy Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Postmenopausal Vaginal Atrophy Drugs Revenue by Manufacturers
3.2.1 Postmenopausal Vaginal Atrophy Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Postmenopausal Vaginal Atrophy Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Postmenopausal Vaginal Atrophy Drugs Price by Manufacturers
3.4 Postmenopausal Vaginal Atrophy Drugs Manufacturing Base Distribution, Product Types
3.4.1 Postmenopausal Vaginal Atrophy Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Postmenopausal Vaginal Atrophy Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Postmenopausal Vaginal Atrophy Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Postmenopausal Vaginal Atrophy Drugs Sales by Product
4.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue by Product
4.3 Postmenopausal Vaginal Atrophy Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Postmenopausal Vaginal Atrophy Drugs Breakdown Data by End User
6 North America
6.1 North America Postmenopausal Vaginal Atrophy Drugs by Countries
6.1.1 North America Postmenopausal Vaginal Atrophy Drugs Sales by Countries
6.1.2 North America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Postmenopausal Vaginal Atrophy Drugs by Product
6.3 North America Postmenopausal Vaginal Atrophy Drugs by End User
7 Europe
7.1 Europe Postmenopausal Vaginal Atrophy Drugs by Countries
7.1.1 Europe Postmenopausal Vaginal Atrophy Drugs Sales by Countries
7.1.2 Europe Postmenopausal Vaginal Atrophy Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Postmenopausal Vaginal Atrophy Drugs by Product
7.3 Europe Postmenopausal Vaginal Atrophy Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Postmenopausal Vaginal Atrophy Drugs by Countries
8.1.1 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales by Countries
8.1.2 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Postmenopausal Vaginal Atrophy Drugs by Product
8.3 Asia Pacific Postmenopausal Vaginal Atrophy Drugs by End User
9 Central & South America
9.1 Central & South America Postmenopausal Vaginal Atrophy Drugs by Countries
9.1.1 Central & South America Postmenopausal Vaginal Atrophy Drugs Sales by Countries
9.1.2 Central & South America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Postmenopausal Vaginal Atrophy Drugs by Product
9.3 Central & South America Postmenopausal Vaginal Atrophy Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs by Countries
10.1.1 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales by Countries
10.1.2 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs by Product
10.3 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs by End User
11 Company Profiles
11.1 Actavis plc
11.1.1 Actavis plc Company Details
11.1.2 Company Business Overview
11.1.3 Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Actavis plc Postmenopausal Vaginal Atrophy Drugs Products Offered
11.1.5 Actavis plc Recent Development
11.2 Bionovo, Inc.
11.2.1 Bionovo, Inc. Company Details
11.2.2 Company Business Overview
11.2.3 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
11.2.5 Bionovo, Inc. Recent Development
11.3 Endoceutics, Inc.
11.3.1 Endoceutics, Inc. Company Details
11.3.2 Company Business Overview
11.3.3 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
11.3.5 Endoceutics, Inc. Recent Development
11.4 Novo Nordisk A/S
11.4.1 Novo Nordisk A/S Company Details
11.4.2 Company Business Overview
11.4.3 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Products Offered
11.4.5 Novo Nordisk A/S Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
11.5.5 Pfizer Inc. Recent Development
11.6 Teva Pharmaceuticals Ltd.
11.6.1 Teva Pharmaceuticals Ltd. Company Details
11.6.2 Company Business Overview
11.6.3 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Products Offered
11.6.5 Teva Pharmaceuticals Ltd. Recent Development
11.7 Therapeutics MD, Inc.
11.7.1 Therapeutics MD, Inc. Company Details
11.7.2 Company Business Overview
11.7.3 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Products Offered
11.7.5 Therapeutics MD, Inc. Recent Development
11.8 Shionogi & Company
11.8.1 Shionogi & Company Company Details
11.8.2 Company Business Overview
11.8.3 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Products Offered
11.8.5 Shionogi & Company Recent Development
11.9 Allergan plc
11.9.1 Allergan plc Company Details
11.9.2 Company Business Overview
11.9.3 Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Allergan plc Postmenopausal Vaginal Atrophy Drugs Products Offered
11.9.5 Allergan plc Recent Development
11.10 Shionogi & Co. Ltd.
11.10.1 Shionogi & Co. Ltd. Company Details
11.10.2 Company Business Overview
11.10.3 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Products Offered
11.10.5 Shionogi & Co. Ltd. Recent Development
12 Future Forecast
12.1 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Regions
12.1.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Forecast by Regions 2019-2025
12.2 Postmenopausal Vaginal Atrophy Drugs Market Forecast by Product
12.2.1 Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Postmenopausal Vaginal Atrophy Drugs Revenue Forecast by Product 2019-2025
12.3 Postmenopausal Vaginal Atrophy Drugs Market Forecast by End User
12.4 North America Postmenopausal Vaginal Atrophy Drugs Forecast
12.5 Europe Postmenopausal Vaginal Atrophy Drugs Forecast
12.6 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Forecast
12.7 Central & South America Postmenopausal Vaginal Atrophy Drugs Forecast
12.8 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Postmenopausal Vaginal Atrophy Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Postmenopausal Vaginal Atrophy Drugs Product Picture
Table Postmenopausal Vaginal Atrophy Drugs Market Segments
Table Key Manufacturers Postmenopausal Vaginal Atrophy Drugs Covered
Table Global Postmenopausal Vaginal Atrophy Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product 2014-2025
Figure Premarin Product Picture
Table Major Manufacturers of Premarin
Figure Vagifem Product Picture
Table Major Manufacturers of Vagifem
Figure Estrace Product Picture
Table Major Manufacturers of Estrace
Figure Estring Product Picture
Table Major Manufacturers of Estring
Figure Femring Product Picture
Table Major Manufacturers of Femring
Table Global Postmenopausal Vaginal Atrophy Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Vaginal Gels
Figure Creams
Figure Tablets
Figure Rings
Figure Patches
Figure Postmenopausal Vaginal Atrophy Drugs Report Years Considered
Figure Global Postmenopausal Vaginal Atrophy Drugs Market Size 2014-2025 (Million US$)
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales 2014-2025 (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Regions 2014-2019 (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Regions 2014-2019
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Regions
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions 2014-2019
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Regions
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Postmenopausal Vaginal Atrophy Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Postmenopausal Vaginal Atrophy Drugs Revenue Share by Manufacturers (2014-2019)
Figure Postmenopausal Vaginal Atrophy Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Postmenopausal Vaginal Atrophy Drugs Price (2014-2019) (USD/Unit)
Table Postmenopausal Vaginal Atrophy Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Postmenopausal Vaginal Atrophy Drugs Product Type
Table Date of International Manufacturers Enter into Postmenopausal Vaginal Atrophy Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by Product (2014-2019) (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by Product (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product in 2018
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Share by Product (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Product (2014-2019)
Figure Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Product in 2018
Table Postmenopausal Vaginal Atrophy Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales by End User (2014-2019) (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Share by End User (2014-2019)
Figure Global Sales Postmenopausal Vaginal Atrophy Drugs Market Share by End User (2014-2019)
Figure Global Sales Postmenopausal Vaginal Atrophy Drugs Market Share by End User in 2018
Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2014-2019) (K Units)
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries
Table North America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries
Figure United States Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Postmenopausal Vaginal Atrophy Drugs Sales by Product (2014-2019) (K Units)
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Postmenopausal Vaginal Atrophy Drugs Market Share by Product
Table North America Postmenopausal Vaginal Atrophy Drugs Sales by End User (2014-2019) (K Units)
Table North America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Postmenopausal Vaginal Atrophy Drugs Market Share by End User
Figure Europe Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries
Table Europe Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries
Figure Germany Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales by Product (2014-2019) (K Units)
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Postmenopausal Vaginal Atrophy Drugs Market Share by Product
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales by End User (2014-2019) (K Units)
Table Europe Postmenopausal Vaginal Atrophy Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Postmenopausal Vaginal Atrophy Drugs Market Share by End User
Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries
Figure China Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Market Share by Product
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Postmenopausal Vaginal Atrophy Drugs Market Share by End User
Figure Central & South America Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries
Figure Brazil Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Postmenopausal Vaginal Atrophy Drugs Market Share by Product
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Postmenopausal Vaginal Atrophy Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Postmenopausal Vaginal Atrophy Drugs Market Share by End User
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Countries
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Market Share by Countries
Figure GCC Countries Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market Share by Product
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Market Share by End User
Table Actavis plc Company Details
Table Actavis plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Actavis plc Recent Development
Table Bionovo, Inc. Company Details
Table Bionovo, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bionovo, Inc. Recent Development
Table Endoceutics, Inc. Company Details
Table Endoceutics, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Endoceutics, Inc. Recent Development
Table Novo Nordisk A/S Company Details
Table Novo Nordisk A/S Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk A/S Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Inc. Recent Development
Table Teva Pharmaceuticals Ltd. Company Details
Table Teva Pharmaceuticals Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceuticals Ltd. Recent Development
Table Therapeutics MD, Inc. Company Details
Table Therapeutics MD, Inc. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Therapeutics MD, Inc. Recent Development
Table Shionogi & Company Company Details
Table Shionogi & Company Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shionogi & Company Recent Development
Table Allergan plc Company Details
Table Allergan plc Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan plc Recent Development
Table Shionogi & Co. Ltd. Company Details
Table Shionogi & Co. Ltd. Postmenopausal Vaginal Atrophy Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shionogi & Co. Ltd. Recent Development
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Postmenopausal Vaginal Atrophy Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Postmenopausal Vaginal Atrophy Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Postmenopausal Vaginal Atrophy Drugs Value Chain
Table Postmenopausal Vaginal Atrophy Drugs Customers List
Table Postmenopausal Vaginal Atrophy Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs